SCHEMBL390627

SCHEMBL390627

COc1ccnc(N2CCN(C(=O)O)CC2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.57
GRM5 P41594 1/20 0.48
HSD17B10 Q99714 4/20 0.48
HPGD P15428 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 4/20 0.47
KMT2A Q03164 2/20 0.47
ALOX15 P16050 1/20 0.47
MEN1 O00255 1/20 0.47
LRRK2 Q5S007 1/20 0.46
LMNA P02545 1/20 0.46
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
PHGDH O43175 1/20 0.46
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5682996 0.83 HRH3 (0.57) HRH3ALDH1A1LRRK2LMNA
SCHEMBL30546118 0.83 HRH3 (0.57) HRH3ALDH1A1LRRK2LMNA
SCHEMBL19468913 0.81 HRH3 (0.53) HRH3GRM5NPSR1KDM4EKMT2A
SCHEMBL20339529 0.81 KDM4E (0.51) HSD17B10HPGDNPSR1ALDH1A1KDM4E
SCHEMBL23630488 0.81 HRH3 (0.58) HRH3L3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL17310115 0.80 HRH4 (0.56) HRH3ALDH1A1LRRK2NOS3NOS1
SCHEMBL30230148 0.80 HRH4 (0.56) HRH3ALDH1A1LRRK2NOS3NOS1
SCHEMBL15228566 0.80 PIK3CA (0.48) GRM5HSD17B10HPGDL3MBTL1ALDH1A1
SCHEMBL5232771 0.80 CCKAR (0.51) HRH3HSD17B10HPGDNPSR1L3MBTL1
SCHEMBL390340 0.80 HRH3 (0.54) HRH3GRM5HSD17B10HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101618-B2 1,4-substituted piperazine derivatives MSD K.K. (JP) 2012-01-24 US disclosed
US-20090062293-A1 1,4-Substituted Piperazine Derivatives MSD K.K. (JP) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062293-A1 1,4-Substituted Piperazine Derivatives GRIN1, GRM1, GRIN2C HRH3 661/4885GRM5 6/4885HSD17B10 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.